Jorsal A, Kistorp C, Holmager P et al (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes ( LIVE )a multicentre, double-blind, randomised, placebo-controlled trial
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH
Available at: Accessed November 7, 2024
If that lawsuit were to succeed, or if Novo Nordisks capacity to produce were to falter, the drugs may end up back on the shortage list
Please take a look at yet another study (L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis) ( this a case where the substance (LCar) itself is beneficial, but the by-products of its beakdown by gut flora are not
But we still dont know